Trial intelligence / Profile preview

Lipidem versus Lipofundin MCT in adults on home parenteral nutrition

2015-000849-23Phase 4Completed

Sponsor
B. Braun
Start
Apr 2017
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in intestinal failure (IF) comparing Lipidem with Lipofundin MCT (2 arms). Primary endpoint: Primary objective. Started Apr 2017; status: completed.

02

Drugs

Lipidemmedium-chain triglycerides + long-chain triglycerides
03

Conditions

intestinal failure (IF)

Beyond the preview

Go deeper on 2015-000849-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000849-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call